Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α 2β 1 receptor

International Journal of Pharmaceutics

Volumn 428, Issue 1-2, 2012, Pages 171-177

  Knudsen, Nina ^a,b   Schiffelers, Raymond M ^c   Jorgensen, Lene ^a   Hansen, Jens ^b   Frokjaer, Sven ^a   Foged, Camilla ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Calcipotriol; Drug delivery; Integrin alpha 2; Liposomes; Nanomedicine; Targeting

Indexed keywords

ARGINYLLYSYLLYSYLHISTIDINE; ASPARAGINASE MACROGOL; CALCIPOTRIOL; CATHELICIDIN; COLECALCIFEROL; COLECALCIFEROL RECEPTOR; CYCLOPEPTIDE; INTEGRIN ALPHA2BETA1 RECEPTOR; INTEGRIN RECEPTOR; LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL CULTURE; CELL INTERACTION; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOCYTOSIS; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; LIPID BILAYER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TARGETING;

ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; CALCITRIOL; CELL LINE, TUMOR; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CHOLECALCIFEROL; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; INTEGRIN ALPHA2BETA1; KERATINOCYTES; LIGANDS; LIPOSOMES; PEPTIDES, CYCLIC; POLYETHYLENE GLYCOLS; RECEPTORS, CALCITRIOL;

EID: 84859431766     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.043     Document Type: Article

References (32)

1. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
2. J. Barsony, I. Renyi, and W. McKoy Subcellular distribution of normal and mutant vitamin D receptors in living cells. Studies with a novel fluorescent ligand J. Biol. Chem. 272 1997 5774 5782 (Pubitemid 27102408)
3. Y. Bury, D. Ruf, C.M. Hansen, A.M. Kissmeyer, L. Binderup, and C. Carlberg Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases J. Invest. Dermatol. 116 2001 785 792 (Pubitemid 32467661)
4. K.D. Call-Culbreath, and M.M. Zutter Collagen receptor integrins: rising to the challenge Curr. Drug Targets 9 2008 139 149 (Pubitemid 351467381)
5. M. DeLuca, C.M. Ward, K. Ohmori, R.K. Andrews, and M.C. Berndt Jararhagin and Jaracetin - novel snake venom inhibitors of the integrin collagen receptor alpha(2)beta(1) Biochem. Biophys. Res. Commun. 206 1995 570 576
6. A.L. Dunehoo, M. Anderson, S. Majumdar, N. Kobayashi, C. Berkland, and T.J. Siahaan Cell adhesion molecules for targeted drug delivery J. Pharm. Sci. 95 2006 1856 1872 (Pubitemid 44433019)
7. H. Grohganz, V. Ziroli, U. Massing, and M. Brandl Quantification of various phosphatidylcholines in liposomes by enzymatic assay AAPS PharmSciTech 4 2003 E63
8. J. Ivaska, J. Kapyla, O. Pentikainen, A.R. Hoffren, J. Hermonen, P. Huttunen, M.S. Johnson, and J. Heino A peptide inhibiting the collagen binding function of integrin alpha I-2 domain J. Biol. Chem. 274 1999 3513 3521 (Pubitemid 29077192)
9. A.M. Jensen, M.B. Llado, L. Skov, E.R. Hansen, J.K. Larsen, and O. Baadsgaard Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells Br. J. Dermatol. 139 1998 984 991 (Pubitemid 29010534)
10. D. Kirpotin, J.W. Park, K. Hong, S. Zalipsky, W.L. Li, P. Carter, C.C. Benz, and D. Papahadjopoulos Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro Biochemistry 36 1997 66 75 (Pubitemid 27024679)
11. N.O. Knudsen, L. Jorgensen, J. Hansen, C. Vermehren, S. Frokjaer, and C. Foged Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity Int. J. Pharm. 416 2011 478 485
12. R.J. Kok, A.J. Schraa, E.J. Bos, H.E. Moorlag, S.A. Asgeirsdottir, M. Everts, D.K. Meijer, and G. Molema Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics Bioconjug. Chem. 13 2002 128 135 (Pubitemid 34119644)
13. G.A. Koning, R.M. Schiffelers, M.H.M. Wauben, R.J. Kok, E. Mastrobattista, G. Molema, T.L.M. ten Hagen, and G. Storm Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis Arthritis Rheum. 54 2006 1198 1208 (Pubitemid 43672932)
14. L.J. Lambert, A.A. Bobkov, J.W. Smith, and F.M. Marassi Competitive interactions of collagen and a jararhagin-derived disintegrin peptide with the integrin alpha 2-I domain J. Biol. Chem. 283 2008 16665 16672
15. R.J. Lee, and P.S. Low Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 1994 3198 3204 (Pubitemid 24237629)
16. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
17. E.S. Lovelace, C.J. Armishaw, M.L. Colgrave, M.E. Wahlstrom, P.F. Alewood, N.L. Daly, and D.J. Craik Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter J. Med. Chem. 49 2006 6561 6568 (Pubitemid 44657450)
18. M. McKeown, G. Knowles, and C.A. McCulloch Role of the cellular attachment domain of fibronectin in the phagocytosis of beads by human gingival fibroblasts in vitro Cell Tissue Res. 262 1990 523 530
19. T. Musacchio, and V.P. Torchilin Recent developments in lipid-based pharmaceutical nanocarriers Front. Biosci. 16 2011 1388 1412
20. U.K. Nassander, P.A. Steerenberg, W.H. de Jong, W.O. van Overveld, C.M. te Boekhorst, L.G. Poels, P.H. Jap, and G. Storm Design of immunoliposomes directed against human ovarian carcinoma Biochim. Biophys. Acta 1235 1995 126 139
21. S. Oliveira, M.M. Fretz, A. Hogset, G. Storm, and R.M. Schiffelers Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA Biochim. Biophys. Acta 1768 2007 1211 1217 (Pubitemid 46553752)
22. W.C. Parks What is the alpha2beta1 integrin doing in the epidermis? J. Invest. Dermatol. 127 2007 264 266
23. M. Peric, S. Koglin, Y. Dombrowski, K. Gross, E. Bradac, A. Buchau, A. Steinmeyer, U. Zugel, T. Ruzicka, and J. Schauber Vitamin D analogs differentially control antimicrobial peptide/alarmin expression in psoriasis PLoS One 4 2009 e6340
24. G. Rouser, S. Fkeischer, and A. Yamamoto Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 1970 494 496
25. R.M. Schiffelers, G.A. Koning, T.L.M. ten Hagen, M.H.A.M. Fens, A.J. Schraa, A.N.P.C. Janssen, R.J. Kok, G. Molema, and G. Storm Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 2003 115 122 (Pubitemid 37288882)
26. R.M. Schiffelers, and G. Storm Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells Int. J. Pharm. 364 2008 258 264
27. Y.H. Su, and J.Y. Fang Drug delivery and formulations for the topical treatment of psoriasis Exp. Opin. Drug Deliv. 5 2008 235 249
28. I. Teige, A. Backlund, L. Svensson, P.H. Kvist, T.K. Petersen, and K. Kemp Induced keratinocyte hyper-proliferation in alpha2beta1 integrin transgenic mice results in systemic immune cell activation Int. Immunopharmacol. 10 2010 107 114
29. D. Tuckwell, D.A. Calderwood, L.J. Green, and M.J. Humphries Integrin alpha 2 I-domain is a binding site for collagens J. Cell Sci. 108 1995 1629 1637
30. F.M. Watt Role of integrins in regulating epidermal adhesion, growth and differentiation EMBO J. 21 2002 3919 3926 (Pubitemid 34857425)
31. G. Weber, J.D. Heilborn, C.I.C. Jimenez, A. Hammarsjo, H. Torma, and M. Stahle Vitamin D induces the antimicrobial protein hCAP18 in human skin J. Invest. Dermatol. 124 2005 1080 1082 (Pubitemid 40629115)
32. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo J. Pharm. Sci. 94 2005 1782 1793 (Pubitemid 41360872)